Prevalence and Clinical Features of Celiac Disease in Healthy School-Aged Children.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
01 2019
Historique:
received: 02 05 2018
accepted: 03 10 2018
pubmed: 13 10 2018
medline: 5 2 2019
entrez: 13 10 2018
Statut: ppublish

Résumé

The aim of this study was to determine the prevalence of celiac disease (CD) in healthy school-aged children in the northern region of Cyprus and to investigate the existence of potential markers that may accompany CD. This is the first study to measure the prevalence of CD in the northern region of Cyprus. This study included 3792 school-aged children who were between the ages of 6 and 10 years between January 2015 and October 2016. CD was screened using total serum IgA, IgA anti-tissue transglutaminase (tTG), and IgA antiendomysial (EMA) antibodies. Subjects with selective IgA deficiency were further tested for IgG-tTG. Small intestinal biopsies were performed on all subjects with tTG antibody positivity. Risk factors and symptoms related to CD were evaluated using questionnaires in both the CD and control groups. Of the 3792 subjects, 39 were antibody positive (IgA-tTG was positive only in 14 subjects, IgA-tTG plus IgA-EMA in 21 subjects, and IgG-tTG in 4 subjects). IgA deficiency was detected in 11 subjects (0.29%). IgG-tTG was positive in 4 subjects with IgA deficiency (36.3%). Intestinal biopsies were performed on 28 of the 39 seropositive subjects. The biopsy findings of 15 children were consistent with CD (IgA-tTG positive in 3, IgA-tTG and IgA-EMA positive in 10, and IgG-tTG positive in 2). Thus, biopsies confirmed CD in 1:256 children (0.39%). Our study, which is the first study of school-aged children from the northern region of Cyprus, revealed that CD is a prevalent disease in this region.

Sections du résumé

BACKGROUND/AIMS
The aim of this study was to determine the prevalence of celiac disease (CD) in healthy school-aged children in the northern region of Cyprus and to investigate the existence of potential markers that may accompany CD. This is the first study to measure the prevalence of CD in the northern region of Cyprus.
METHODS
This study included 3792 school-aged children who were between the ages of 6 and 10 years between January 2015 and October 2016. CD was screened using total serum IgA, IgA anti-tissue transglutaminase (tTG), and IgA antiendomysial (EMA) antibodies. Subjects with selective IgA deficiency were further tested for IgG-tTG. Small intestinal biopsies were performed on all subjects with tTG antibody positivity. Risk factors and symptoms related to CD were evaluated using questionnaires in both the CD and control groups.
RESULTS
Of the 3792 subjects, 39 were antibody positive (IgA-tTG was positive only in 14 subjects, IgA-tTG plus IgA-EMA in 21 subjects, and IgG-tTG in 4 subjects). IgA deficiency was detected in 11 subjects (0.29%). IgG-tTG was positive in 4 subjects with IgA deficiency (36.3%). Intestinal biopsies were performed on 28 of the 39 seropositive subjects. The biopsy findings of 15 children were consistent with CD (IgA-tTG positive in 3, IgA-tTG and IgA-EMA positive in 10, and IgG-tTG positive in 2). Thus, biopsies confirmed CD in 1:256 children (0.39%).
CONCLUSIONS
Our study, which is the first study of school-aged children from the northern region of Cyprus, revealed that CD is a prevalent disease in this region.

Identifiants

pubmed: 30311156
doi: 10.1007/s10620-018-5320-0
pii: 10.1007/s10620-018-5320-0
doi:

Substances chimiques

Autoantibodies 0
Immunoglobulin A 0
Immunoglobulin G 0
Protein Glutamine gamma Glutamyltransferase 2 EC 2.3.2.13
Transglutaminases EC 2.3.2.13
GTP-Binding Proteins EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

173-181

Investigateurs

Adem Karbuz (A)
Serhat Guler (S)
Alper Kacar (A)
Soner Sazak (S)
Figen Ince (F)
Mine Ozdil Cirkinoglu (M)
Bircan Kavaz (B)
Hulya Madi (H)
Sevgi Oksuz (S)
Bekir Yigit Develi (BY)
Nazife Oner (N)
Kamuran Aribuka (K)
Saziye Guçlu (S)
Remzi Gardiyanoglu (R)
Nurcin Incirli (N)

Références

J Pediatr Gastroenterol Nutr. 2000 Nov;31(5):513-9
pubmed: 11144436
Pediatrics. 2013 Mar;131(3):e687-94
pubmed: 23420914
Pediatrics. 2014 Feb;133(2):211-8
pubmed: 24420802
Arch Intern Med. 2003 Feb 10;163(3):286-92
pubmed: 12578508
Aliment Pharmacol Ther. 2012 Mar;35(5):540-51
pubmed: 22239821
Gastroenterology. 1992 Jan;102(1):330-54
pubmed: 1727768
J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):507-13
pubmed: 26815017
Pediatrics. 2009 Dec;124(6):1572-8
pubmed: 19948628
Am J Gastroenterol. 2011 Aug;106(8):1512-7
pubmed: 21691340
J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):80-4
pubmed: 15187786
J Clin Gastroenterol. 2017 May/Jun;51(5):412-416
pubmed: 27306936
BMC Pediatr. 2008 Sep 11;8:35
pubmed: 18786241
Pediatrics. 2010 Mar;125(3):e518-24
pubmed: 20123763
Gastroenterology. 2005 Apr;128(4 Suppl 1):S57-67
pubmed: 15825128
Ann Med. 2010 Dec;42(8):587-95
pubmed: 21070098
J Gastroenterol. 2018 Mar;53(3):377-386
pubmed: 28589338
JAMA Pediatr. 2015 Mar;169(3):e1525
pubmed: 25730696
Acta Paediatr. 2013 Jul;102(7):749-54
pubmed: 23600795
Pediatrics. 2013 Oct;132(4):e924-31
pubmed: 24019416
J Clin Gastroenterol. 2008 Mar;42(3):256-60
pubmed: 18223500
J Clin Gastroenterol. 2005 Sep;39(8):689-91
pubmed: 16082278
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Pediatrics. 2015 Apr;135(4):627-34
pubmed: 25733751
J Pediatr Gastroenterol Nutr. 2014 Jul;59 Suppl 1:S7-9
pubmed: 24979197
Gut. 2013 Jan;62(1):43-52
pubmed: 22345659
Nat Rev Immunol. 2013 Apr;13(4):294-302
pubmed: 23493116
Gastroenterology. 2017 Aug;153(2):410-419.e17
pubmed: 28461188
J Pediatr Gastroenterol Nutr. 2005 Jan;40(1):1-19
pubmed: 15625418
Br J Gen Pract. 2007 Aug;57(541):636-42
pubmed: 17688758
J Clin Gastroenterol. 2019 Feb;53(2):e61-e67
pubmed: 29095420
Dig Liver Dis. 2011 Aug;43(8):604-8
pubmed: 21342796
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60
pubmed: 22197856
Scand J Gastroenterol. 2005 Jan;40(1):15-9
pubmed: 15841709
Eur J Gastroenterol Hepatol. 2007 Nov;19(11):982-7
pubmed: 18049168
BMC Public Health. 2014 Aug 07;14:806
pubmed: 25099430
J Clin Gastroenterol. 2016 Aug;50(7):551-60
pubmed: 26535478
N Engl J Med. 2007 Oct 25;357(17):1731-43
pubmed: 17960014
Clin Chem Lab Med. 2010 May;48(5):685-91
pubmed: 20201743
Nat Med. 2012 Feb 26;18(3):441-5
pubmed: 22366952
J Clin Pathol. 2002 Jul;55(7):488-94
pubmed: 12101191
Am J Gastroenterol. 2008 Sep;103(9):2360-5; quiz 2366
pubmed: 18702652
J Pediatr Gastroenterol Nutr. 1999 Jan;28(1):26-30
pubmed: 9890464

Auteurs

Omer Faruk Beser (OF)

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Health Sciences, Okmeydani Education and Training Hospital, Istanbul, Turkey. ofbeser@gmail.com.

Emine Gulluelli (E)

Director of Basic Health Care Office, Northern Cyprus Ministry of Health, Nicosia, Cyprus.

Fugen Cullu Cokugras (F)

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.

Tulay Erkan (T)

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.

Tufan Kutlu (T)

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.

Rasit Vural Yagci (RV)

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Ege University Medical Faculty, Izmir, Turkey.

Firuze Erbek Alp (F)

Department of Pediatrics, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.

Gulten Ercal (G)

Cyprus Turkish Pediatric Association, Nicosia, Cyprus.

Nuray Kepil (N)

Department of Pathology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.

Mine Kucur (M)

Department of Medical Biochemistry, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH